跳至主要内容
临床试验/NCT04347382
NCT04347382已完成3 期

The Role of Honey and Nigella Sativa in the Management of COVID-19; A Randomized Controlled, Open-label, Add-on Trial in Pakistan

Sohaib Ashraf2 个研究点 分布在 1 个国家目标入组 313 人开始时间: 2020年4月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Sohaib Ashraf
入组人数
313
试验地点
2
主要终点
Days required to get a positive COVID-19 PCR to negative

研究概览

简要总结

To evaluate the effectiveness of Nigella Sativa and honey stirred in 250 ml of distilled water 12 hourly till patient becomes asymptomatic or a maximum of 14 days with standard hospital care versus standard hospital care alone with placebo capsule and 250 ml water, in clearing the COVID-19 nucleic acid from throat and nasal swab, lowering disease detrimental effects on HRCT chest/X-ray and severity of symptoms along with duration of hospital stay till day 14th day of follow up and 30 days mortality (primary outcomes).

详细描述

This cohort, adaptive, randomized, double armed group, controlled, Investigator Initiated interventional study is designed to demonstrate the superiority of a combination of black cumin with honey over standard care in SARS-CoV-2 (COVID-19) infected patients who consent to randomization following a new diagnosis in Pakistan with an SSC-2 score of > 5 with positive RT-PCR of COVID-19.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed SARS-CoV-2 (COVID-19) infection by a positive test result with SSC-2 score> 5
  • Patients admitted in Corona centers

排除标准

  • Participants not giving consent.
  • Pregnant and lactating females.
  • History of allergy to any drug being administered in this study
  • Severely terminally ill patients
  • Patients on Nil Per Oral

研究组 & 干预措施

Nigella Sativa & Honey Group

Experimental

Drug: Nigella Sativa seed Powder 80 mg/Kg/day grinded in capsule upto a max of 14 days) Drug: Natural Honey 1gm/kg/day orally upto a max of 14 days)

along with standard medical care

干预措施: Honey (Drug)

Nigella Sativa & Honey Group

Experimental

Drug: Nigella Sativa seed Powder 80 mg/Kg/day grinded in capsule upto a max of 14 days) Drug: Natural Honey 1gm/kg/day orally upto a max of 14 days)

along with standard medical care

干预措施: Nigella Sativa / Black Cumin (Drug)

Standard Medical Care

Placebo Comparator

Standard supportive medical care prescribed by treating physician, Lahore which includes standard symptomatic care along with use of antibacterial or antiviral (if advised by pulmonologist or infectious disease specialist)

干预措施: Placebos (Drug)

结局指标

主要结局

Days required to get a positive COVID-19 PCR to negative

时间窗: upto max 14 days

Severity of symptoms progression

时间窗: upto max 14 days

Clinically disease progression will be evaluated depending upon the severity of symptoms being classified as mild, moderate and severe.

Duration of Hospital Saty

时间窗: upto max 14 day

Duration of hospital stay would be categorized as the number of days the patient stayed in the ward during treatment. The date of admission and date of discharge would give us total duration of stay.

30 day mortality

时间窗: 30 days

30 days mortality rate in each arm

Clinical Grade Status

时间窗: 0, 4, 6, 8, 10 and 12 day

grade 1 (not hospitalized, no evidence of infection and resumption of normal activities), grade 2 (not hospitalized, but unable to resume normal activities), grade 3 (hospitalized, not requiring supplemental oxygen), grade 4 (hospitalized, requiring supplemental oxygen), grade 5 (hospitalized, requiring nasal high-flow oxygen therapy and/or noninvasive mechanical ventilation), grade 6 (hospitalized, requiring ECMO and/or invasive mechanical ventilation) and grade 7 (death).

Fever

时间窗: 13 days

Degree of fever

次要结局

  • Oxygen Saturation at room air(upto max of 14 days)

研究者

发起方
Sohaib Ashraf
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sohaib Ashraf

Post-Graduate Resident Cardiology

Sheikh Zayed Federal Postgraduate Medical Institute

研究点 (2)

Loading locations...

相似试验

Honey & Nigella Sativa Trial Against COVID-19 | 临床试验